You are here

SBIR Phase II: Automated Analysis of Body Fluid Chemistry Using MHD-Based Microfluidics

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0750328
Agency Tracking Number: 0611074
Amount: $500,000.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: BT
Solicitation Number: NSF 05-605
Timeline
Solicitation Year: N/A
Award Year: 2008
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
535 W RESEARCH BLVD, SUITE 135,
FAYETTEVILLE, AR 72701
United States
DUNS: 125518428
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Christine Evans
 PhD
 (479) 571-2592
 ceevans@sfc-fluidics.com
Business Contact
 Christine Evans
Title: PhD
Phone: (479) 571-2592
Email: ceevans@sfc-fluidics.com
Research Institution
N/A
Abstract

This Phase II SBIR Proposal develops a suite of labs-on-a-chip that can be used to establish the metabolic health of an individual in real-time from a finger-prick sample of blood. Each disposable chip will contain all reagents necessary to run the assay and all waste will be stored on the chip. These sealed, self-contained assay chips will be based on magnetohydrodynamic microfluidics and microelectrochemical detection and will allow for the simultaneous quantization of multiple biomarkers. The biomarkers chosen for this project have been linked to an individual?s metabolic health in a broad range of high importance areas, including aging, cardiovascular health, neurochemical health, and prepregnancy health. The ability to quantify the biomarkers simultaneously will allow for assessment of an individual?s metabolic status and determination of an intervention strategy within the time scale of a single visit to the doctor. Any necessary follow-up visit will provide immediate feedback on success or failure of the intervention strategy. This point-of-care testing platform will allow both doctor and patient to take a more proactive stance in the management of an individual?s metabolic status. The broader impacts of this research meet a need for improved preconception care. This technology can be expanded to include additional biomarkers that will allow for convenient, inexpensive screening of a number of health issues, including pernicious anemia, renal disease, neurochemical health and
cardiovascular health that could broaden its impact on improving the Nation's healtcare.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government